Free Trial

Gain Therapeutics (GANX) SEC Filings & 10K Form

Gain Therapeutics logo
$1.58 -0.03 (-1.55%)
Closing price 07/18/2025 04:00 PM Eastern
Extended Trading
$1.57 -0.01 (-0.95%)
As of 07/18/2025 07:59 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

Recent Gain Therapeutics SEC Filings

DateFilerForm TypeView
07/17/2025
6:30 AM
Gain Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
07/17/2025
6:37 AM
Gain Therapeutics (Filer)
Form 424B5
06/25/2025
4:30 PM
Gain Therapeutics (Issuer)
Melincoff Gwen A (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/25/2025
4:30 PM
Gain Therapeutics (Issuer)
GOLDSTEIN DOV A MD (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/25/2025
4:30 PM
Gain Therapeutics (Issuer)
HASLER HANS PETER (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/25/2025
4:30 PM
Gain Therapeutics (Issuer)
RICHMAN ERIC I (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/25/2025
4:30 PM
Gain Therapeutics (Issuer)
Riley Jeffrey Scott (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/25/2025
4:30 PM
Gain Therapeutics (Issuer)
Nicaise Claude (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/25/2025
4:30 PM
Gain Therapeutics (Issuer)
Islam Khalid (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/24/2025
4:09 PM
Gain Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
04/17/2025
3:05 PM
Gain Therapeutics (Filer)
Form PRE 14A
04/10/2025
3:49 PM
Gain Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
03/21/2025
7:00 PM
Gain Therapeutics (Issuer)
Mack Gene (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/21/2025
7:00 PM
Fuggetta Gianluca (Reporting)
Gain Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
02/06/2025
3:50 PM
Gain Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
01/15/2025
4:00 PM
Gain Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
01/07/2025
8:00 PM
Gain Therapeutics (Issuer)
Mack Gene (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
01/07/2025
4:00 PM
Gain Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
12/23/2024
7:30 AM
Gain Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
11/14/2024
3:02 PM
Gain Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
10/21/2024
4:22 PM
Gain Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
10/08/2024
3:30 PM
Gain Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
09/19/2024
5:15 AM
Gain Therapeutics (Filer)
Form S-8
Registration statement under Securities Act of 1933 to be offered to employees pursuant to certain plans  
09/06/2024
4:00 PM
Gain Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
09/06/2024
4:01 PM
Gain Therapeutics (Filer)
Form 424B5
08/12/2024
4:23 PM
Gain Therapeutics (Issuer)
Islam Khalid (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
08/12/2024
4:23 PM
Gain Therapeutics (Issuer)
Mack Gene (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
(Data available from 1/1/2016 forward)


Related Companies and Tools


This page (NASDAQ:GANX) was last updated on 7/20/2025 by MarketBeat.com Staff
From Our Partners